Neuried, Germany
AMSilk, known by its slogan βBiogenius Materialsβ, is a leading player in the realm of advanced biomaterials, innovatively utilizing silk proteins. Founded in 2008 and headquartered in Germany, the company is positioned at the cutting edge of bioengineering technologies like DNA editing, protein engineering, and precision fermentation.
AMSilk transforms biogenic materials into pioneering materials such as fibers, yarns, hydrogels, and silk powders. These materials offer high-performance qualities beneficial for industries including textiles, homecare, biomedical, and automobiles, meeting diverse needs and setting new industry standards.
The latest financial milestone for AMSilk was a β¬25.00M Series C funding round completed in April 2023, supported by prominent investors like Novo Holdings, Cargill, MIG AG, and Athos Group. Such robust backing emphasizes confidence in their potential to drive transformation across multiple sectors through sustainable, innovative material solutions.
Bolt (Projects Holdings)
